Prawo i regulacje · 19/12/2025

Janssen Pharmaceuticals, Inc. Seeks DEA Approval for Bulk Manufacturing of Controlled Substances

Janssen Pharmaceuticals, Inc. has submitted a request to the U.S. government to be registered as a bulk manufacturer of controlled substances, a process that requires approval from the Drug Enforcement Administration (DEA).